---
$id: https://graph.org.ai/products/commodity/51273006
$type: Product
source: UNSPSC
code: "51273006"
title: "Mepivacaine"
class: "51273000"
classTitle: "Anaesthetic piperidines"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mepivacaine

**UNSPSC Code**: 51273006
**Class**: [Anaesthetic piperidines](Anaesthetic piperidines.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C15H22N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B6E06QE59J, chemically known as 2-piperidinecarboxamide, n-(2,6-dimethylphenyl)-1-methyl- but generally known as mepivacaine, which bears US NIH Compound Identifier 4062. European Medicines Agency schedules Mepivacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14514MIG. The term MEPIVACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules mepivacaine in its Anatomical Therapeutic Chemical (ATC) Classification. MEPIVACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mepivacaine under HS 29333999 and SITC 51574. As of Q4 2014, MEPIVACAINE remains the US FDA Preferred Term for this commodity. Mepivacaine bears US NLM identifiers UMLS ID C0025384 and NCI Concept Code C61831. SMILES: O=C(NC1C(CCCC1C)C)C1N(CCCC1)C.

